Search research articles
Contact Us
Filters
Showing results (81-90 of 89) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 89 results.
Biodiversity Data Journal
|
February 10, 2023
The complete mitochondrial genome of <i>Coccotorusbeijingensis</i> Lin et Li, 1990 (Coleoptera, Curculionidae, Curculioninae, Anthonomini) and its phylogenetic implications
Sai Jiang, Lina Jiang, Ran Li, et al.
BMC Cancer
|
December 18, 2024
The impact of high-risk cytogenetic abnormalities in extramedullary multiple myeloma in the era of novel agents: insights from a multicenter study
Dong Liang, Yurong Yan, Shenrui Bai, et al.
Annals of Medicine
|
April 30, 2025
Clinical outcome of ≥2% circulating tumor cells in newly diagnosed multiple myeloma: insights from a multicenter study
Dong Liang, Yurong Yan, Shenrui Bai, et al.
Hematological Oncology
|
June 23, 2025
Clinical Outcome of Extramedullary Multiple Myeloma in the Era of Novel Agents: Insights From a Multicenter Study
Dong Liang, Yurong Yan, Qiaoli Wang, et al.
Journal of Hematology & Oncology
|
June 24, 2024
Individualized dynamic frailty-tailored therapy (DynaFiT) in elderly patients with newly diagnosed multiple myeloma: a prospective study
Yingjie Zhang, Xinyue Liang, Weiling Xu, et al.
European Journal of Medicinal Chemistry
|
October 15, 2018
Discovery, cocrystallization and biological evaluation of novel piperidine derivatives as high affinity Ls-AChBP ligands possessing α7 nAChR activities
Xicheng Yang, Jian Shen, Lulu Jiang, et al.
American Journal of Hematology
|
October 30, 2022
Proposed risk-scoring model for estimating the prognostic impact of 1q gain in patients with newly diagnosed multiple myeloma
Peiyu Yang, Haimin Chen, Xinyue Liang, et al.
American Journal of Cancer Research
|
March 14, 2025
Dissecting the high-risk property of 1q gain/amplification in patients with newly diagnosed multiple myeloma
Xinyue Liang, Weiling Xu, Fan Zhou, et al.
Clinical Medicine (London, England)
|
October 3, 2024
Dynamics of minimal residual disease and its clinical implications in multiple myeloma: A retrospective real-life analysis
Weiling Xu, Xinyue Liang, Shanshan Liu, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 89) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 89 results.
Biodiversity Data Journal
|
February 10, 2023
The complete mitochondrial genome of <i>Coccotorusbeijingensis</i> Lin et Li, 1990 (Coleoptera, Curculionidae, Curculioninae, Anthonomini) and its phylogenetic implications
Sai Jiang, Lina Jiang, Ran Li, et al.
BMC Cancer
|
December 18, 2024
The impact of high-risk cytogenetic abnormalities in extramedullary multiple myeloma in the era of novel agents: insights from a multicenter study
Dong Liang, Yurong Yan, Shenrui Bai, et al.
Annals of Medicine
|
April 30, 2025
Clinical outcome of ≥2% circulating tumor cells in newly diagnosed multiple myeloma: insights from a multicenter study
Dong Liang, Yurong Yan, Shenrui Bai, et al.
Hematological Oncology
|
June 23, 2025
Clinical Outcome of Extramedullary Multiple Myeloma in the Era of Novel Agents: Insights From a Multicenter Study
Dong Liang, Yurong Yan, Qiaoli Wang, et al.
Journal of Hematology & Oncology
|
June 24, 2024
Individualized dynamic frailty-tailored therapy (DynaFiT) in elderly patients with newly diagnosed multiple myeloma: a prospective study
Yingjie Zhang, Xinyue Liang, Weiling Xu, et al.
European Journal of Medicinal Chemistry
|
October 15, 2018
Discovery, cocrystallization and biological evaluation of novel piperidine derivatives as high affinity Ls-AChBP ligands possessing α7 nAChR activities
Xicheng Yang, Jian Shen, Lulu Jiang, et al.
American Journal of Hematology
|
October 30, 2022
Proposed risk-scoring model for estimating the prognostic impact of 1q gain in patients with newly diagnosed multiple myeloma
Peiyu Yang, Haimin Chen, Xinyue Liang, et al.
American Journal of Cancer Research
|
March 14, 2025
Dissecting the high-risk property of 1q gain/amplification in patients with newly diagnosed multiple myeloma
Xinyue Liang, Weiling Xu, Fan Zhou, et al.
Clinical Medicine (London, England)
|
October 3, 2024
Dynamics of minimal residual disease and its clinical implications in multiple myeloma: A retrospective real-life analysis
Weiling Xu, Xinyue Liang, Shanshan Liu, et al.
Page
of 9